|
Dear Young Women E-List Member,
Welcome to this edition of the Young Women E-Bulletin. We hope that you find the information of interest.
Field of Women LIVE Sydney Registrations Are Now Open
The website is up and running and you can register for the event online. So far, 1,708 people have registered and we need more! BCNA is calling on 13,000 people - representing the number of Australians diagnosed with breast cancer in 2007 - to stand together and create the first ever Sydney Field of Women LIVE before the Sydney Swans v St Kilda match on Saturday evening, 11 August 2007. All welcome - supporters, friends, survivors and anyone else!
YOUNG ACTION ON BREAST CANCER (YABC) present: Up Close and Personal to 13 - 14 October 2007.
This is a two day conference for young women affected by breast cancer. Preparations for the 1st National Young Women's Conference have started to take shape. Most speakers have been confirmed and a full list will appear on the website by the end of this month. The plenary sessions will be around fertility, psychosocial needs, treatment and stories from young women.
Workshops will include some of the following topics:
- New Normal, this will look at work related issues, survivorship, long term and newly diagnosed experiences
- Sexuality will cover a range of topics from being single and living with breast cancer through to same sex relationships
- Dealing With Children, a mix of expert speakers and young women's experiences
- Exploring the unique issues of the very young, a special workshop for women under 33
- Living with advanced disease; Advocacy; and Creative and Complimentary Workshops.
Registration details will be available at the end of June.
You can email YABC to join their Email List to receive regular Conference updates:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
.
The following information has been gathered from various sources and is not endorsed by BCNA.
News Updates
Here is the latest news coming out of the American Society of Clinical Oncology (ASCO) Conference that was held in Chicago from 1-5 June 2007.
Molecular Signatures Characterize Early Stage Breast Cancer Arising in Young Women and have Prognostic and Therapeutic Implications Independent of ER Status
American Society of Clinical Oncology: breast cancer in young women has a poorer prognosis, is less likely hormone sensitive, and has yet to be defined as a unique biologic phenotype. The identification of molecular pathways unique to young women should enable refinement of treatment strategies.
Abstract
To find out more about the news from the conference click on the first link above.
Research Updates
The Safety of Breast-Conserving Therapy in Patients with Breast Cancer Aged ≤40 years
In Cancer: the objectives of this study were to examine the probability of local control after breast-conserving therapy (BCT) in a large population of patients with early-stage breast cancer aged 40 years and to determine which factors had prognostic value.
Abstract
Poor Outcome of Hormone Receptor-Positive Breast Cancer at Very Young Age Is Due to Tamoxifen Resistance: Nationwide Survival Data in Korea - A Report From the Korean Breast Cancer Society
In the Journal of Clinical Oncology: breast cancer in very young women (age < 35 years) is uncommon and poorly understood. The researchers sought to evaluate the prognosis and treatment response of these patients compared with women ages 35 to 50 years.
Abstract
Fertility issues
Discussion of Fertility Preservation with Newly Diagnosed Patients: Oncologists' Views
In the Journal of Cancer Survivorship: although physician discussion with patients regarding fertility preservation (FP) options prior to cancer treatment can provide important information for survivors concerning their future fertility, little is known about the extent to which physicians discuss FP with patients.
Abstract
Predictors of Ovarian Reserve in Young Women with Breast Cancer
In the British Journal of Cancer: ovarian reserve can be diminished following treatment for breast cancer. The researchers evaluated biochemical and biophysical parameters of ovarian reserve in their patients. Biochemical and biophysical tests of ovarian reserve were performed simultaneously in young (age 22-42 years), regularly menstruating women with breast cancer (n=22) and age-matched controls (n=24).
Abstract
|
